ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML,  | Related Articles | Citation Tracking

Prevalence of Helicobacter pylori Resistance to Metronidazole, Clarithromycin, Amoxicillin, Tetracycline, and Furazolidone in Brazil
Sergio Mendonça, Christina Ecclissato, M.S. Sartori, Anita Paula Ortiz Godoy, Rosângela Aparecida Guerzoni, Maristela Degger, and José Pedrazzoli, Jr.
  Clinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, Bragança Paulista, SP, Brazil
Correspondence to Reprint requests to: José Pedrazzoli Jr, M.D., Clinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, Av. São Francisco de Assisi 218, 12900–000, Bragança Paulista, SP, Brazil. E-mail: pedrazz@dglnet.com.br
Copyright Blackwell Science, Inc.

ABSTRACT

Background. Helicobacter pylori infection is associated with a wide range of digestive diseases and is very prevalent in developing countries, although few data exist on the susceptibility of H. pylori to antimicrobials commonly used in eradication schedules in these countries. The aim of this study was to evaluate the resistance of H. pylori to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in dyspeptic Brazilian patients.

Material and Methods. Ninety consecutive H. pylori–positive patients were enrolled. Resistance was evaluated by an agar dilution test.

Results. Resistance to metronidazole was detected in 38 patients (42%); to amoxicillin in 26 individuals (29%); to clarithromycin in 6 patients (7%); to tetracycline in 6 patients (7%); and to furazolidone in 4 individuals (4%). Thirteen strains were resistant to two agents, and eight strains were resistant to three antimicrobials.

Conclusions. These results confirm the need for culture and susceptibility testing to define H. pylori resistance patterns in particular geographical areas before the general use of an eradication schedule. They also suggest the possibility of resistance to such antimicrobials as amoxicillin or tetracycline in geographical areas with a high prevalence of H. pylori infection and still not fully evaluated for antimicrobial susceptibility.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1523-5378.2000.00011.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
E-mail alerts
Sign up for e-alerts
Click here
Sign Up Now
Wiley Medical Twitter